Abbott Laboratories

ABT | News | $107.28 1.91% 0.18% 10M

(0.0% 1d) (-4.2% 1m) (-3.9% 1y) (0.8% 2d) (-0.6% 3d) (-1.5% 7d) (Infinity% volume)
Earnings Calendar: 2024-01-24
Market Cap: $ 186,150,570,524
http://www.abbott.com
Sec Filling | Patents | 107000 employees

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

cardiovascular nutrition heart optical brands diagnostics

add to watch list Paper trade email alert is off